Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Johnson and Johnson
McKesson
Chubb
Accenture
Queensland Health
Healthtrust
Argus Health
Cantor Fitzgerald
Boehringer Ingelheim

Generated: October 22, 2017

DrugPatentWatch Database Preview

FULVICIN P/G 330 Drug Profile

« Back to Dashboard

Which patents cover Fulvicin P/g 330, and what generic Fulvicin P/g 330 alternatives are available?

Fulvicin P/g 330 is a drug marketed by Chartwell Rx and is included in one NDA.

The generic ingredient in FULVICIN P/G 330 is griseofulvin, ultramicrocrystalline. There is one drug master file entry for this compound. Additional details are available on the griseofulvin, ultramicrocrystalline profile page.

Summary for Tradename: FULVICIN P/G 330

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list50
Clinical Trials: see list133
Patent Applications: see list4,635
Drug Prices:see details
DailyMed Link:FULVICIN P/G 330 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx
FULVICIN P/G 330
griseofulvin, ultramicrocrystalline
TABLET;ORAL061996-004Apr 6, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Daiichi Sankyo
Cipla
Cantor Fitzgerald
Fuji
Deloitte
Citi
Baxter
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot